TREATMENT, DIAGNOSTIC, AND METHOD FOR DISCOVERING ANTAGONIST USING SPARC SPECIFIC MIRNAS

Amphoteric liposome formulation

Method of cancer treatment using siRNA silencing

INHIBITION OF EXTRACELLULAR SIGNAL-REGULATED KINASE 1/2 AS A TREATMENT FOR CARDIAC HYPERTROPHY AND HEART FAILURE

Composition and method for in vivo and in vitro attenuation of gene expression using double stranded RNA

Methods for Controlling Stem Cell Differentiation

Therapeutic Medicament for Chronic Obstructive Pulmonary Disease (COPD), Cystic Fibrosis, and Pulmonary Hypertension

Nucleic Acid Molecules and Collections Thereof, Their Application and Identification

Oligoribonucleotide inhibitors of NRF2 and methods of use thereof for treatment of cancer

COMPOSITIONS AND METHODS FOR REGULATING GENE TRANSCRIPTION

Compositions and methods for identifying and targeting cancer cells of alimentary canal origin

Novel Gene Therapy Approach For Treating The Metabolic Disorder Obesity

Annexin II and uses thereof

Novel therapeutic targets in cancer

Use of complement inhibitors to treat ocular diseases

Methods and compositions for regulating cell cycle checkpoints

Serum Response Factor and Myocardin Control Alzheimer Cerebral Amyloid Angiopathy

Oligonucleotides with alternating segments of locked and non-locked nucleotides

Nucleic acid functionalized nanoparticles for therapeutic applications

RNAi-mediated inhibition of connexin 43 for treatment of IOP-related conditions

MODULATION OF CHREBP EXPRESSION

Compositions and methods for decreasing microrna expression for the treatment of neoplasia

Direct Reversal Of The Suppressive Function Of CD4+Regulatory T Cells Via Toll-Like Receptor 8 Signaling

COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF THE HAMP GENE

MicroRNA fingerprints during human megakaryocytopoiesis

Recurrent gene fusions in prostate cancer

Compositions of asymmetric interfering RNA and uses thereof

Diagnostic And Therapeutic Uses Of Augmenter Of Liver Regeneration In Inflammatory Conditions

siRNA targeting cyclin-dependent kinase 4 (CDK4)

ANTISENSE COMPOUNDS HAVING ENHANCED ANTI-MICRORNA ACTIVITY

Retrotransposon Inhibition in Therapy

INHIBITION STAT-1

Modulation of eIF4E-BP2 expression

TRANS-SPLICING MEDIATED PHOTODYNAMIC THERAPY

Compounds for the modulation of beta-catenin expression

Modulating immune system development and function through microRNA MIR-146

Glycoconjugates of RNA interference agents

Determinants of sensitivity to chemotherapeutic agents

Polyamides for nucleic acid delivery

GENE THERAPY FOR CANCER USING SMALL INTERFERING RNA SPECIFIC TO ANT2 AND A METHOD TO OVERCOME TOLERANCE TO ANTITUMOR AGENT

Method for treating cancer using anti-Wnt2 monoclonal antibodies and siRNA

AGENTS FOR IMPROVING INFLAMMATORY BOWEL DISEASE

MIR-150 FOR THE TREATMENT OF BLOOD DISORDERS

2'-Modified Oligonucleotides

SUPPRESSION OF POLYMORPHIC ALLELES

Modified short interfering RNA

Functional nucleic acid ligands to fluorescent proteins

Compositions and methods for the suppression of target polynucleotides from

USE OF COMPOUNDS THAT INTERFERE WITH THE HEDGEHOG SIGNALING PATHWAY FOR THE MANUFACTURE OF A MEDICAMENT FOR PREVENTING, INHIBITING, AND/OR REVERSING OCULAR DISEASES RELATED WITH OCULAR NEOVASCULARIZATION

miR-10 Regulated Genes and Pathways as Targets for Therapeutic Intervention

MiR-124 regulated genes and pathways as targets for therapeutic intervention

Modulation of eIF4E expression

RNA interference mediated inhibition of hypoxia inducible factor 1 (HIF1) gene expression using short interfering nucleic acid (siNA)

Multitargeting interfering RNAs having two active strands and methods for their design and use

miR-21 REGULATED GENES AND PATHWAYS AS TARGETS FOR THERAPEUTIC INTERVENTION

Folliculin-specific antibodies and methods of detection

siRNA targeting connective tissue growth factor (CTGF)

Compositions and methods for siRNA inhibition of HIF-1 alpha

Nucleic acid compositions and methods of introducing nucleic acids into cells

MODULATION OF STAT 6 EXPRESSION FOR THE TREATMENT OF AIRWAY HYPERRESPONSIVENESS

Constitutively active fragments of eukaryotic heat shock RNA

Methods to reprogram splice site selection in pre-messenger RNAs

Interfering RNA molecules

RNA sequence-specific mediators of RNA interference

IDENTIFICATION OF JAK/STAT PATHWAY MODULATING GENES BY GENOME WIDE RNAI SCREENING

Methods of Generating Cardiomyocytes and Cardiac Progenitors and Compositions

RNA SILENCING COMPOSITIONS AND METHODS FOR THE TREATMENT OF HUNTINGTON'S DISEASE

Transgenic plants modified for reduced cadmium transport, derivative products, and related methods

Specific GRP78 expression-inhibition RNAi sequence, medicine thereof and method thereof

Methods and compositions for treating keratin hyperproliferative disorders

HUMAN RIBOSOMAL DNA (rDNA) AND RIBOSOMAL RNA (rRNA) NUCLEIC ACIDS AND USES THEREOF

Identification of a micro-RNA that activates expression of β-myosin heavy chain

METHOD OF TREATING NEURODEGENERATIVE DISEASE

Treatment of CNS conditions

Methods and compositions involving miRNA and miRNA inhibitor molecules

METHOD FOR DEMONSTRATING PRESENCE OR ABSENCE OF MARKERS ASSOCIATED WITH THE PRESENCE AND/OR THE CHEMOSENSITIVITY OF TUMORS

Modulation of C-reactive protein expression

Cosmetic designs and products using intronic RNA

Nucleic Acid-Mediated Treatment of Diseases or Conditions Related to Levels of Vascular Endothelial Growth Factor Receptor (VEGF-R)

DROUGHT TOLERANT PLANTS AND RELATED CONSTRUCTS AND METHODS INVOLVING GENES ENCODING miR827

siRNA targeting myeloid cell leukemia sequence 1

siRNA targeting tumor necrosis factor receptor superfamily member 1A

miR-200 REGULATED GENES AND PATHWAYS AS TARGETS FOR THERAPEUTIC INTERVENTION

miR-20 Regulated Genes and Pathways as Targets for Therapeutic Intervention

COMPOSITIONS AND METHODS FOR MODULATION OF PDX-1

FUNCTIONS AND TARGETS OF LET-7 MICRO RNAS

Identification of a JAK2 mutation in polycythemia vera

Novel siRNAS and methods of use thereof

siRNA targeting hypoxia-inducible factor 1

Compositions and methods for activating genes of interest

Antisense oligonucleotides (ODN) against Smad7 and uses thereof in medical field

COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING ASTHMA OR OTHER ALLERGIC OR INFLAMMATORY DISEASES

Use of inhibitors of scinderin and/or ephrin-A1 for treating tumors

Compositions and methods for modulation of LMNA expression

Novel siRNAS and methods of use thereof

Composition and method for in vivo and in vitro attenuation of gene expression using double stranded RNA

METHOD OF INHIBITING EXPRESSION OF TARGET MRNA USING SIRNA CONSISTING OF NUCLEOTIDE SEQUENCE COMPLEMENTARY TO SAID TARGET MRNA

DKKL-1 splice product modulators for cancer diagnosis and therapy

RNA Interference Mediating Small RNA Molecules

SiRNA targeting KRAS

RNA interference mediated treatment of Alzheimer's disease using short interfering nucleic acid (siNA)

SiRNA silencing of genes expressed in cancer

METHOD FOR TREATING CANCER USING INTERFERENCE RNA

ATF4 As A Therapeutic Target In Alzheimers Disease And Other Neurological Disorders

MicroRNAs

RNA interference mediated inhibition of interleukin and interleukin receptor gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of interleukin and interleukin receptor gene expression using short interfering nucleic acid (siNA)

Cell transfecting formulations of small interfering RNA related compositions and methods of making and use

Kinase suppressor of Ras inactivation for therapy of Ras mediated tumorigenesis

Transcription factor decoy

DETECTION AND MODULATION OF IAPs AND NAIP FOR THE DIAGNOSIS AND TREATMENT OF PROLIFERATIVE DISEASE

MANIPULATING SP1 ACTIVITY TO IMPROVE THERAPEUTIC CLONING

Pancreatic cancer targets and uses thereof

SENSITIZING A CELL TO CANCER TREATMENT BY MODULATING THE ACTIVITY OF A NUCLEIC ACID ENCODING RPS27L PROTEIN

RNA interference mediated inhibition of placental growth factor gene expression using short interfering nucleic acid (SINA)

RNA INTERFERENCE MEDIATED INHIBITION OF NF-KAPPA B/ REL-A GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)

RNA INTERFERENCE MEDIATED INHIBITION OF PROLIFERATION CELL NUCLEAR ANTIGEN (PCNA) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)

RNA INTERFERENCE MEDIATED INHIBITION OF ANGIOPOIETIN GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)

MICRORNA TARGET SITE BLOCKING OLIGOS AND USES THEREOF

RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (SINA)

Methods and compositions for regulating cell cycle progression via the miR-106B family

METHOD OF DIAGNOSING COLON AND GASTRIC CANCERS

Inducible SIRNA expression cassette and method of use

LOW DENSITY LIPOPROTEIN RECEPTOR-MEDIATED siRNA DELIVERY

miR-15, miR-26, miR-31, miR-145, miR-147, miR-188, miR-215, miR-216, miR-331, mmu-miR-292-3P REGULATED GENES AND PATHWAYS AS TARGETS FOR THERAPEUTIC INTERVENTION

MICRORNAS DIFFERENTIALLY EXPRESSED IN PANCREATIC DISEASES AND USES THEREOF

Reduction of off-target RNA interference toxicity

Rna constructs

Antisense modulation of PTP1B expression

Compositions and methods for cancer diagnosis and therapy

Compositions for Bacterial Mediated Gene Silencing and Methods of Using the Same

siRNA targeting nucleoporin 62kDa (Nup62)

Compositions for conferring tolerance to viral disease in social insects, and the use thereof

RNA ANTAGONIST COMPOUNDS FOR THE INHIBITION OF APO-B100 EXPRESSION

Use of apoptosis-specific eIF-5A siRNA to down regulate expression of proinflammatory cytokines to treat sepsis

RNA interference for the treatment of gain-of-function disorders

Method of diagnosing and treating cancer using B-catenin splice variants

Immunosuppression compound and treatment method

Antisense oligonucleotide constructs based on beta-arabinofuranose and its analogues

Pharmaceutical composition containing decoy and method of using the same

Methods and compositions for the treatment of eye disorders with increased intraocular pressure

Methods and compositions for the treatment of eye disorders with increased intraocular pressure

NUCLEIC ACIDS HYBRIDIZABLE TO MICRO RNA AND PRECURSORS THEREOF

ALLELE-SPECIFIC SILENCING OF DISEASE GENES

Polyamides for nucleic acid delivery

Antisense microRNA and uses therefor

RNA interference mediated inhibition of matrix metalloproteinase 13 (MMP13) gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of muscarinic colinergic receptor gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of Stearoyl-CoA desaturase (SCD) gene expression using short interfering nucelic acid (siNA)

RNA INTERFERENCE MEDIATED INHIBITION OF MYOSTATIN GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)

RNA interference mediated inhibition of Fos gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of MYC and/or MYB gene expression using short interfering nucleic acid (siNA)

Methods and compositions for the treatment of eye disorders with increased intraocular pressure

Methods and compositions for the treatment of eye disorders with increased intraocular pressure

Methods and compositions for the treatment of eye disorders with increased intraocular pressure

Methods and compositions for the treatment of eye disorders with increased intraocular pressure

Oligonucleotide decoys and methods of use

Construction of pool of interfering nucleic acids covering entire RNA target sequence and related compositions

Reagents and Methods for miRNA Expression Analysis and Identification of Cancer Biomarkers

Methods and compositions for controlling efficacy of RNA silencing

Higher-order cellular information processing devices

Technology for the Preparation of Microparticles

RNA interference mediated inhibition of XIAP gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of vascular cell adhesion molecule (VCAM) gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of GRB2 associated binding protein (GAB2) gene expression using short interfering nucleic acid (siNA)

USE OF EIF-5A1 SIRNA TO PROTECT ISLETS CELLS FROM APOPTOSIS AND TO PRESERVE THEIR FUNCTIONALITY

Tumor inhibition by modulating sprouty expression of activity

RNAi modulation of SCAP and therapeutics uses thereof

Tetrahydropyran nucleic acid analogs

siRNA targeting transducin (beta)-like 3 (TBL3)

NFIA in glial fate determination, glioma therapy and astrocytoma treatment

Sequence-specific inhibition of small RNA function

siRNA targeting TATA box binding protein (TBP)-associated factor (TAF1)

Compositions for enhancing transport of molecules into cells

Modulation of eIF4E-BP2 expression

Modulation of transthyretin expression

Compositions and Methods for Regulating Gene Expression

Antisense oligonucleotides capable of inhibiting the formation of capillary tubes by endothelial cells and methods of treating ophthalmic and dermatological diseases

Methods of treatment of acute renal failure

Control of gene expression using a complex of an oligonucleotide and a regulatory peptide

Polynucleotide for Target Gene

Activation of nuclear factor kappa B

Nucleic acid-enzyme complex

Pharmaceutical composition for treating cancer

Prognostic, diagnostic, and cancer therapeutic uses of FANCI and FANCI modulating agents

Methods for identifying compounds for the treatment of type 1 diabetes

Modulation of exon recognition in pre-mRNA by interfering with the secondary RNA structure

IG20 splice variants therapeutics for cancer

G-quartet oligonucleotides that target hypoxia-inducible factor 1-α (HIF1α)

Modulation of apolipoprotein (a) expression

METHODS OF INHIBITING TUMOR CELL PROLIFERATION WITH FOXM1 siRNA

Compositions and methods for treatment of colorectal cancer

Plant microRNAs and methods of use thereof

siRNA targeting inner centromere protein antigens (INCENP)

Method and compositions for inhibiting MAGE protein interaction with KAP-1

FINE PARTICULATE PREPARATION COMPRISING COMPLEX OF NUCLEIC ACID MOLECULE AND COLLAGEN

Methods for the identification of microRNA and their applications in research and human health

Methods for Identifying Compounds for the Treatment of Type 1 Diabetes

RNAi MEDIATED KNOCKDOWN OF NUMA FOR CANCER THERAPY

Compositions and methods for inhibiting expression of anti-apoptotic genes

Peripherin and Neurofilament Light Protein Splice Variants in Amyotrophic Lateral Sclerosis (ALS)

Optical sorting method

Chn-1/Chip-Antagonists For The Treatment Of Muscular Diseases

METABOLOMIC CANCER TARGETS

METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION BY DOUBLE-STRANDED RNA

siRNA targeting minichromosome maintenance deficient 3 (MCM3)

METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION BY DOUBLE-STRANDED RNA

MicroRNA and methods for inhibiting same

Nucleic Acid-Lipopolymer Compositions

Composition, method of preparation & application of concentrated formulations of condensed nucleic acids with a cationic lipopolymer

Methods and kits for linking polymorphic sequences to expanded repeat mutations

INTRACELLULAR EXPRESSION AND DELIVERY OF siRNAs IN MAMMALIAN CELLS

METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION BY DOUBLE-STRANDED RNA

RNAi-RELATED INHIBITION OF TNFa SIGNALING PATHWAY FOR TREATMENT OF MACULAR EDEMA

RNAi-RELATED INHIBITION OF TNFalpha SIGNALING PATHWAY FOR TREATMENT OF OCULAR ANGIOGENESIS

RNA INTERFERENCE SUPPRESSION OF NEURODEGENERATIVE DISEASES AND METHODS OF USE THEREOF

Angiogenesis Affecting Polypeptides, Proteins, and Composition, and Methods of Use Thereof

METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION BY DOUBLE-STRANDED RNA

siRNA targeting 1-acylglycerol-3-phosphate O-acyltransferase 2 (AGPAT2)

METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION BY DOUBLE-STRANDED RNA

Centrosomal proteins and secretion

INHIBITOR OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR ALPHA COACTIVATOR 1

Decoy Nucleic Acid to Synoviolin Gene Promoter

METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION BY DOUBLE-STRANDED RNA

Use of GILZ protein expressed in dendritic cells to modulate an antigen-specific immune response

MARKERS FOR DIAGNOSIS OF CANCER AND ITS USE

Compositions and methods for studying and treating inflammatory diseases and disorders

siRNA targeting ribosomal protein S2 (RPS2)

siRNA targeting kinesin spindle protein (KSP)

RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)

Rnai Agents for Maintenance of Stem Cells

Double-Stranded Oligonucleotides

Method Of Screening Compound Regulating The Translation Of Specific mRNA

METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION BY DOUBLE-STRANDED RNA

MODIFICATION OF DOUBLE-STRANDED RIBONUCLEIC ACID MOLECULES

Method for maintaining pluripotency of stem/progenitor cells

Antisense oligonucleotides for prevention of metastasis formation of cancer cells

Method for the diagnosis and prognosis of malignant diseases

Recombinant DNA constructs and methods for controlling gene expression

DECOY-OLIGNUCLEOTIDE INHIBITION OF CD40-EXPRESSION

Inhibiting formation of atherosclerotic lesions

Biosensors based on directed assembly of particles

siRNA targeting nuclear receptor interacting protein 1 (NRIP1)

Use of the microRNA miR-1 for the treatment, prevention, and diagnosis of cardiac conditions

COMPOUNDS FOR THE MODULATION OF BETA-CATENIN EXPRESSION

Method for the Production of Suitable Dna Constructs for Specific Inhibition of Gene Expression by Rna Interference

Dek protein compositions and methods of using the same

Nucleic Acids For Inhibiting Hairless Protein Expression and Methods of Use Thereof

Methods and compositions for controlling efficacy of RNA silencing

INTRANASAL DELIVERY OF NUCLEIC ACID MOLECULES

METHOD FOR SUSTAINABLE TRANSGENE TRANSCRIPTION

Amino acid lipids and uses thereof

Therapeutic uses of factors which inhibit or neutralize MIF activity

PRODUCTION OF ARTIFICIAL MICRORNAS USING SYNTHETIC MICRORNA PRECURSORS

Gene silencing

Treatment of HSV-related pathologies using plasmids that make ssDNA

Agent for Regulating Bone Formation

Combined hairpin-antisense compositions and methods for modulating expression

DNA constructs for specific inhibition of gene expression by RNA interference

Use of Sirnas in Organ Storage/Reperfusion Solutions

Engineered Dopamine Neurons and Uses Thereof

Methods for inhibition of proliferative disease, including hepatocellular carcinoma

Bacteria mediated gene silencing

Isis Pharmaceuticals, Inc.

Nucleic acid functionalized nanoparticles for therapeutic applications

siRNA targeting proprotein convertase subtilisin/kexin type 9 (PCSK9)

Agents, compositions and methods for treating pathologies in which regulating an ache-associated biological pathway is beneficial

MicroRNA-based methods and compositions for the diagnosis, prognosis and treatment of solid cancers

Beta-actin and RPS21 promoters and uses thereof

siRNA targeting vascular endothelial growth factor receptor 1 (VEGFR1)

Treatment and prevention of hyperproliferative conditions in humans and antisense oligonucleotide inhibition of human replication-initiation proteins

Microrna inhibition for the treatment of inflammation and myeloproliferative disorders

Gene expression and pain

Cell cycle arrest and apoptosis

NUCLEIC ACID COMPOUNDS FOR INHIBITING APOB GENE EXPRESSION AND USES THEREOF

Methods of inhibiting smooth muscle cell migration and proliferation

Host cell protein knock-out cells for production of therapeutic proteins

Targeted integration into the PPP1R12C locus

Bacterially derived intact minicells that encompass plasmid free functional nucleic acid for in vivo delivery to mammalian cells

Antisense oligonucleotides capable of inhibiting the formation of capillary tubes by endothelial cells

MODULATION OF THE EXPRESSION OF STAT-1-DEPENDENT GENES

Method of treating autoimmune diseases

siRNA targeting protein tyrosine phosphatase-1B (PTP1B)

siRNA targeting casitas B cell lymphoma-B (CBL-B)

Multiple shRNA Expression Vectors and Methods of Construction

Intranuclear protein transduction through a nucleoside salvage pathway

Oligoribonucleotides and methods of use thereof for treatment of alopecia, acute renal failure and other diseases

Oligonucleotide complex compositions and methods of use as gene alteration tools

Methods for modulating cellular and organismal phenotypes

SATB1: A DETERMINANT OF MORPHOGENESIS AND TUMOR METASTASIS

Method for eliciting an immune response to human telomerase reverse transcriptase

RNAi probes targeting cancer-related proteins

Suppression of nuclear factor-κB dependent processes using oligonucleotides

Methods and compositions for modulating vascular integrity

Rna Interference Suppression of Neurodegenerative Diseases and Methods of Use Thereof

Promoter variants for expressing genes in a fungal cell

Lipids, lipid complexes and use thereof

Targeting a Secreted Pro-Apoptotic Factor for Cancer Therapeutics

ShRNA molecules and methods of use thereof

RNA interference mediating small RNA molecules